News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Interview Jul 19, 2024 Expanding the Alimentiv Site Network: An Interview With Peter Westerveld The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring… Read Now
Publication Apr 1, 2023 Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis Read Now
Publication Feb 8, 2023 Patients With Crohn’s Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review Read Now
Publication Oct 4, 2022 CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease Read Now
Publication Jul 16, 2022 Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization Read Now
Publication Jul 3, 2022 Placebo rates in randomized controlled trials of proctitis therapy: A systematic review and meta-analysis Read Now
Publication Jun 24, 2022 Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn’s Disease: Meta-Analysis of Randomised Controlled Trials Read Now
